DE60001266D1 - Betahistin-hältige formulierung mit kontrollierter wirkstofffreisetzung - Google Patents

Betahistin-hältige formulierung mit kontrollierter wirkstofffreisetzung

Info

Publication number
DE60001266D1
DE60001266D1 DE60001266T DE60001266T DE60001266D1 DE 60001266 D1 DE60001266 D1 DE 60001266D1 DE 60001266 T DE60001266 T DE 60001266T DE 60001266 T DE60001266 T DE 60001266T DE 60001266 D1 DE60001266 D1 DE 60001266D1
Authority
DE
Germany
Prior art keywords
betahistin
active ingredients
controlled active
related formulation
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60001266T
Other languages
English (en)
Other versions
DE60001266T2 (de
Inventor
Flavio Fabiani
Enrico Frimonti
Mauro Valenti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FORMENTI FARMACEUTICI SpA
Original Assignee
FORMENTI FARMACEUTICI SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FORMENTI FARMACEUTICI SpA filed Critical FORMENTI FARMACEUTICI SpA
Publication of DE60001266D1 publication Critical patent/DE60001266D1/de
Application granted granted Critical
Publication of DE60001266T2 publication Critical patent/DE60001266T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
DE60001266T 1999-03-05 2000-02-28 Betahistin-hältige formulierung mit kontrollierter wirkstofffreisetzung Expired - Fee Related DE60001266T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000454A IT1309591B1 (it) 1999-03-05 1999-03-05 Composizioni a rilascio controllato di betaistina.
PCT/EP2000/001642 WO2000053162A1 (en) 1999-03-05 2000-02-28 Controlled-release compositions of betahistine

Publications (2)

Publication Number Publication Date
DE60001266D1 true DE60001266D1 (de) 2003-02-27
DE60001266T2 DE60001266T2 (de) 2003-08-28

Family

ID=11382165

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60001266T Expired - Fee Related DE60001266T2 (de) 1999-03-05 2000-02-28 Betahistin-hältige formulierung mit kontrollierter wirkstofffreisetzung

Country Status (37)

Country Link
EP (1) EP1158963B1 (de)
JP (1) JP2002538197A (de)
KR (1) KR20010102498A (de)
CN (1) CN1165295C (de)
AR (1) AR029154A1 (de)
AT (1) ATE231392T1 (de)
AU (1) AU762532B2 (de)
BG (1) BG105807A (de)
BR (1) BR0008739A (de)
CA (1) CA2364226A1 (de)
CO (1) CO5170438A1 (de)
CZ (1) CZ299510B6 (de)
DE (1) DE60001266T2 (de)
DK (1) DK1158963T3 (de)
EE (1) EE200100453A (de)
ES (1) ES2189739T3 (de)
GE (1) GEP20033078B (de)
HK (1) HK1042246B (de)
HR (1) HRP20010650A2 (de)
HU (1) HUP0200243A2 (de)
ID (1) ID30127A (de)
IL (1) IL145263A0 (de)
IT (1) IT1309591B1 (de)
MX (1) MXPA01008893A (de)
NO (1) NO319135B1 (de)
NZ (1) NZ513949A (de)
PE (1) PE20001547A1 (de)
PL (1) PL196290B1 (de)
PT (1) PT1158963E (de)
RU (1) RU2248791C2 (de)
SI (1) SI1158963T1 (de)
SK (1) SK284584B6 (de)
TR (1) TR200102566T2 (de)
UA (1) UA65652C2 (de)
WO (1) WO2000053162A1 (de)
YU (1) YU64001A (de)
ZA (1) ZA200107318B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004064807A1 (en) * 2003-01-23 2004-08-05 Amorepacific Corporation Sustained-release preparations and method for producing the same
SI1493435T1 (sl) 2003-07-04 2008-10-31 Formenti Farmaceutici Spa Betahistinski sestavki s kontroliranim sproĺ äśanjem
US7728015B2 (en) 2004-04-22 2010-06-01 Mor Research Applications Ltd. Compositions for weight management
CA2553309A1 (en) 2004-04-22 2005-11-03 Mor Research Applications Ltd. Method of food intake management
WO2006009403A1 (en) * 2004-07-22 2006-01-26 Amorepacific Corporation Sustained-release preparations containing topiramate and the producing method thereof
JP2006176461A (ja) * 2004-12-24 2006-07-06 Dai Ichi Seiyaku Co Ltd 粒状物
WO2009143572A1 (en) 2008-05-27 2009-12-03 The University Of Melbourne Methods of treating mammals with eustachian tube dysfunctions
EP2314296A1 (de) * 2009-10-22 2011-04-27 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Im Mund zerfallende Betahistin Tabletten
EP2491930A1 (de) * 2011-02-25 2012-08-29 Deva Holding Anonim Sirketi Pharmazeutische Kombination von Betahistin mit Trimetazidin
DE102012105528A1 (de) 2012-06-25 2014-01-02 Hennig Arzneimittel Gmbh & Co. Kg Arzneiform zur Freisetzung von Wirkstoffen
WO2015053620A1 (en) * 2013-10-07 2015-04-16 Disphar International B.V. Betahistine composition
PT3431078T (pt) * 2017-07-20 2021-04-21 Intas Pharmaceuticals Ltd Composições orais sólidas de libertação prolongada não pulsáteis de betaistina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2432313A1 (fr) * 1978-08-01 1980-02-29 Foulhoux Pierre Nouvelle forme galenique de la betahistine et son procede d'obtention
GB2280604B (en) * 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents
AU744156B2 (en) * 1996-10-28 2002-02-14 General Mills Inc. Embedding and encapsulation of controlled release particles

Also Published As

Publication number Publication date
CO5170438A1 (es) 2002-06-27
ZA200107318B (en) 2002-09-04
CN1165295C (zh) 2004-09-08
BR0008739A (pt) 2001-12-26
MXPA01008893A (es) 2002-10-23
SK12492001A3 (sk) 2001-12-03
HK1042246A1 (en) 2002-08-09
JP2002538197A (ja) 2002-11-12
ATE231392T1 (de) 2003-02-15
AU762532B2 (en) 2003-06-26
CZ299510B6 (cs) 2008-08-20
YU64001A (sh) 2004-05-12
GEP20033078B (en) 2003-10-27
ITMI990454A1 (it) 2000-09-05
EE200100453A (et) 2002-12-16
BG105807A (bg) 2002-03-29
HRP20010650A2 (en) 2002-10-31
NZ513949A (en) 2003-10-31
ES2189739T3 (es) 2003-07-16
CZ20013186A3 (cs) 2002-02-13
WO2000053162A1 (en) 2000-09-14
CA2364226A1 (en) 2000-09-14
NO20014301L (no) 2001-09-04
CN1342069A (zh) 2002-03-27
PL350232A1 (en) 2002-11-18
EP1158963A1 (de) 2001-12-05
NO20014301D0 (no) 2001-09-04
UA65652C2 (uk) 2004-04-15
KR20010102498A (ko) 2001-11-15
PL196290B1 (pl) 2007-12-31
PE20001547A1 (es) 2001-01-29
HK1042246B (zh) 2005-06-03
SK284584B6 (sk) 2005-07-01
ID30127A (id) 2001-11-08
PT1158963E (pt) 2003-06-30
HUP0200243A2 (en) 2002-06-29
RU2248791C2 (ru) 2005-03-27
DE60001266T2 (de) 2003-08-28
SI1158963T1 (en) 2003-04-30
AR029154A1 (es) 2003-06-18
IL145263A0 (en) 2002-06-30
NO319135B1 (no) 2005-06-20
IT1309591B1 (it) 2002-01-24
AU3283100A (en) 2000-09-28
EP1158963B1 (de) 2003-01-22
TR200102566T2 (tr) 2002-01-21
DK1158963T3 (da) 2003-04-28

Similar Documents

Publication Publication Date Title
DE69918074D1 (de) Makrolid-formulierung mit verzögerter wirkstoffabgabe
DE69928085D1 (de) Dosierungsform mit verlängerter wirkstoffabgabe
ID28232A (id) Formulasi farmasi dengan pelepasan terkontrol
DE69922964D1 (de) Ranolazinhaltige arzneimittel mit verzögerter wirkstoffabgabe
DE69821940D1 (de) Landwirtschaftlich aktive inhaltsstoffe enthaltende mikropartikel
PT1006792E (pt) Formulacao agroquimica
NO20026037L (no) Sötvareprodukt som inneholder aktive bestanddeler
DE60003938D1 (de) Wirkstoffe in hydrogel-mikroperlen
ATE263541T1 (de) Kosmetische formulierung
ID22878A (id) Komposisi aktif secara terapi
DK1060695T3 (da) Stabelbar stol
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
EE200000595A (et) Toimeaine viimine kandjamaatriksisse
DE60012938D1 (de) Hautreinigungszusammensetzung mit verbesserter stabilität
DE60015556D1 (de) Flüssige pestizidzusammensetzung
NO20020793D0 (no) Virkestoffkombinasjon med clonidin
DE59804823D1 (de) Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
DE69919490D1 (de) Puder mit fettlöslichem wirkstoff
DE60001266D1 (de) Betahistin-hältige formulierung mit kontrollierter wirkstofffreisetzung
HUP0300357A3 (en) Control of parasites in animals, the novel active ingredients applied and compositions containing the same
DE69821977D1 (de) Flüssige, insektizide aufgiessformulierung
DE502004001227D1 (de) Kosmetische Zubereitungen mit Wirkstoffen in Mikrokapseln
PL349393A1 (en) Sulphonyloxazolamines as therapeutic active ingredients
ATE250092T1 (de) Polyolformulierung
NO20016147D0 (no) Biologiske aktive materialer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee